Alzheimer’s patients in Britain’s state-run health service are unlikely to get access to Eisai and Biogen’s new Leqembi drug after […]
UK State Health Service Declares New Alzheimer’s Drug Too Expensive for Widespread Use Read More »
WASHINGTON – On Tuesday, a bipartisan group of lawmakers called on the Biden administration to ramp up scrutiny of U.S.
US Lawmakers Call for Increased Oversight of Clinical Trials Conducted in China Read More »
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer Read More »
Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to
Mpox-Linked Stocks Extend Rally Into Second Week Read More »
On Monday, the U.S. Food and Drug Administration delayed traditional approval for Liquidia Corp’s (NASDAQ: LQDA) inhaled drug for types
Liquidia (NASDAQ: LQDA) Stock Tumbles as FDA Delays Traditional Approval for Lung Drug Read More »
Shares in companies making and developing products against mpox surged on Friday as the European Union’s public health body raised
Shares of Mpox Vaccine Developers Rally as Virus Spreads Beyond African Borders Read More »
COPENHAGEN – Novo Nordisk’s (NYSE: NVO) Pharmatech unit will build a 1.5 billion Danish crown ($221 million) plant in Denmark
Novo Nordisk (NYSE: NVO) to Build $220 Million Raw Materials Plant in Denmark Read More »
On Friday, British drugmaker GSK (NYSE: GSK) said it would seek a dismissal of an upcoming Zantac case in Florida,
GSK (NYSE: GSK) to Seek Dismissal of Florida Zantac Case Over Prostate Cancer Claims Read More »
The U.S. announced the final prices of its first-ever negotiation over prescription drugs on Thursday, with Merck’s (NYSE: MRK) diabetes
US Announces Prices in Medicare Drug Negotiations Read More »
Copyright © 2024 abbonews.com
